10725819
Kidney, hrr
items
https://raw.githubusercontent.com/jamesd4335/hrr2/master/hrr_pipes.csl
0
date
desc
197
https://healthresearchreport.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-e2b89d5697c7814d6f1c0cf5b2421b71%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VHNRZQ47%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rathi%20et%20al.%22%2C%22parsedDate%22%3A%222007-11-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EVitamin%20C-induced%20hyperoxaluria%20causing%20reversible%20tubulointerstitial%20nephritis%20and%20chronic%20renal%20failure%3A%20a%20case%20report%3C%5C%2Fb%3E%23%23%212007%20%7C%20Rathi%20S%2C%20Kern%20W%2C%20et%20al.%20%7C%20%3Ci%3EJournal%20of%20Medical%20Case%20Reports%3C%5C%2Fi%3E.%202007%3B1%281%29%3A155.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1752-1947-1-155%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1752-1947-1-155%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vitamin%20C-induced%20hyperoxaluria%20causing%20reversible%20tubulointerstitial%20nephritis%20and%20chronic%20renal%20failure%3A%20a%20case%20report%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shradha%22%2C%22lastName%22%3A%22Rathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Kern%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Lau%22%7D%5D%2C%22abstractNote%22%3A%22Vitamin%20C%20is%20a%20precursor%20of%20oxalate%20and%20promoter%20of%20its%20absorption%2C%20potentially%20causing%20hyperoxaluria.%20Malabsorption%20causes%20Calcium%20%28Ca%29%20chelation%20with%20fatty%20acids%2C%20producing%20enteric%20hyperoxaluria.%22%2C%22date%22%3A%222007-11-27%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2F1752-1947-1-155%22%2C%22ISSN%22%3A%221752-1947%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1752-1947-1-155%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-02-04T18%3A16%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22C8NXXF9N%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Massey%20et%20al.%22%2C%22parsedDate%22%3A%222005-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EAscorbate%20Increases%20Human%20Oxaluria%20and%20Kidney%20Stone%20Risk%3C%5C%2Fb%3E%23%23%212005%20%7C%20Massey%20LK%2C%20Liebman%20M%2C%20et%20al.%20%7C%20%3Ci%3EThe%20Journal%20of%20Nutrition%3C%5C%2Fi%3E.%202005%3B135%287%29%3A1673-1677.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjn%5C%2F135.7.1673%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjn%5C%2F135.7.1673%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ascorbate%20Increases%20Human%20Oxaluria%20and%20Kidney%20Stone%20Risk%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%20K.%22%2C%22lastName%22%3A%22Massey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Liebman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20A.%22%2C%22lastName%22%3A%22Kynast-Gales%22%7D%5D%2C%22abstractNote%22%3A%22Currently%2C%20the%20recommended%20upper%20limit%20for%20ascorbic%20acid%20%28AA%29%20intake%20is%202000%20mg%5C%2Fd.%20However%2C%20because%20AA%20is%20endogenously%20converted%20to%20oxalate%20and%20appears%20to%20increase%20the%20absorption%20of%20dietary%20oxalate%2C%20supplementation%20may%20increase%20the%20risk%20of%20kidney%20stones.%20The%20effect%20of%20AA%20supplementation%20on%20urinary%20oxalate%20was%20studied%20in%20a%20randomized%2C%20crossover%2C%20controlled%20design%20in%20which%20subjects%20consumed%20a%20controlled%20diet%20in%20a%20university%20metabolic%20unit.%20Stoneformers%20%28n%20%3D%2029%3B%20SF%29%20and%20age-%20and%20gender-matched%20non-stoneformers%20%28n%20%3D%2019%3B%20NSF%29%20consumed%201000%20mg%20AA%20twice%20each%20day%20with%20each%20morning%20and%20evening%20meal%20for%206%20d%20%28treatment%20A%29%2C%20and%20no%20AA%20for%206%20d%20%28treatment%20N%29%20in%20random%20order.%20After%205%20d%20of%20adaptation%20to%20a%20low-oxalate%20diet%2C%20participants%20lived%20for%2024%20h%20in%20a%20metabolic%20unit%2C%20during%20which%20they%20were%20given%20136%20mg%20oxalate%2C%20including%2018%20mg%2013C2%20oxalic%20acid%2C%202%20h%20before%20breakfast%3B%20they%20then%20consumed%20a%20controlled%20very%20low-oxalate%20diet%20for%2024%20h.%20Of%20the%2048%20participants%2C%2019%20%2812%20stoneformers%2C%207%20non-stoneformers%29%20were%20identified%20as%20responders%2C%20defined%20by%20an%20increase%20in%2024-h%20total%20oxalate%20excretion%20%26gt%3B%2010%25%20after%20treatment%20A%20compared%20with%20N.%20Responders%20had%20a%20greater%2024-h%20Tiselius%20Risk%20Index%20%28TRI%29%20with%20AA%20supplementation%20%281.10%20%5Cu00b1%200.66%20treatment%20A%20vs.%200.76%20%5Cu00b1%200.42%20treatment%20N%29%20because%20of%20a%2031%25%20increase%20in%20the%20percentage%20of%20oxalate%20absorption%20%2810.5%20%5Cu00b1%203.2%25%20treatment%20A%20vs.%208.0%20%5Cu00b1%202.4%25%20treatment%20N%29%20and%20a%2039%25%20increase%20in%20endogenous%20oxalate%20synthesis%20with%20treatment%20A%20than%20during%20treatment%20N%20%28544%20%5Cu00b1%20131%20A%20vs.%20391%20%5Cu00b1%2071%20%5Cu03bcmol%5C%2Fd%20N%29.%20The%201000%20mg%20AA%20twice%20each%20day%20increased%20urinary%20oxalate%20and%20TRI%20for%20calcium%20oxalate%20kidney%20stones%20in%2040%25%20of%20participants%2C%20both%20stoneformers%20and%20non-stoneformers.%22%2C%22date%22%3A%222005-07-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjn%5C%2F135.7.1673%22%2C%22ISSN%22%3A%220022-3166%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjn%5C%2F135.7.1673%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-02-04T18%3A57%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22A9F42LWN%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lawton%20et%20al.%22%2C%22parsedDate%22%3A%221985-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EAcute%20Oxalate%20Nephropathy%20After%20Massive%20Ascorbic%20Acid%20Administration%3C%5C%2Fb%3E%23%23%211985%20%7C%20Lawton%20JM%2C%20Conway%20LT%2C%20et%20al.%20%7C%20%3Ci%3EArchives%20of%20Internal%20Medicine%3C%5C%2Fi%3E.%201985%3B145%285%29%3A950-951.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Farchinte.1985.00360050220044%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Farchinte.1985.00360050220044%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Oxalate%20Nephropathy%20After%20Massive%20Ascorbic%20Acid%20Administration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Lawton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%20T.%22%2C%22lastName%22%3A%22Conway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20T.%22%2C%22lastName%22%3A%22Crosson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20A.%22%2C%22lastName%22%3A%22Abraham%22%7D%5D%2C%22abstractNote%22%3A%22%5Cu2022%20A%20single%2045-g%20dose%20of%20intravenous%20ascorbic%20acid%2C%20a%20metabolic%20precursor%20of%20oxalate%2C%20was%20administered%20to%20a%20patient%20as%20adjuvant%20therapy%20for%20primary%20amyloidosis%20and%20the%20nephrotic%20syndrome.%20Acute%20oliguric%20renal%20failure%20occurred.%20Postmortem%20histopathologic%20examination%20of%20renal%20tissue%20revealed%20extensive%20intratubular%20deposition%20of%20crystalline%20material%2C%20which%20was%20confirmed%20as%20calcium%20oxalate%20by%20a%20microincineration%20technique.%20There%20were%20no%20extrarenal%20deposits%20of%20calcium%20oxalate.%20Plasma%20oxalate%20and%20ascorbic%20acid%20concentrations%20were%20increased.%20We%20conclude%20that%20therapy%20with%20high-dose%20ascorbic%20acid%20is%20a%20potential%20cause%20of%20oxalate%20nephropathy.%28Arch%20Intern%20Med%201985%3B145%3A950-951%29%22%2C%22date%22%3A%221985-05-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1001%5C%2Farchinte.1985.00360050220044%22%2C%22ISSN%22%3A%220003-9926%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Farchinte.1985.00360050220044%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T20%3A13%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22NRECJ43B%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22McAllister%20et%20al.%22%2C%22parsedDate%22%3A%221984-10-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3ERenal%20Failure%20Secondary%20to%20Massive%20Infusion%20of%20Vitamin%20C%3C%5C%2Fb%3E%23%23%211984%20%7C%20McAllister%20CJ%2C%20Scowden%20EB%2C%20et%20al.%20%7C%20%3Ci%3EJAMA%3C%5C%2Fi%3E.%201984%3B252%2813%29%3A1684.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1984.03350130016019%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1984.03350130016019%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Renal%20Failure%20Secondary%20to%20Massive%20Infusion%20of%20Vitamin%20C%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20J.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20B.%22%2C%22lastName%22%3A%22Scowden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Lawrence%22%2C%22lastName%22%3A%22Dewberry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Richman%22%7D%5D%2C%22abstractNote%22%3A%22To%20the%20Editor.%5Cu2014We%20feel%20compelled%20to%20report%20the%20complications%20of%20high-dose%20vitamin%20C%20infusion%20in%20patients%20with%20renal%20insufficiency.%20Vitamin%20C%2C%20one%20of%20whose%20main%20metabolites%20is%20oxalate%2C%20can%20produce%20permanent%20renal%20failure%20in%20patients%20with%20preexisting%20renal%20insufficiency.Report%20of%20a%20Case.%5Cu2014A%2070-year-old%20man%20with%20documented%20renal%20insufficiency%20came%20to%20a%20%5C%22chelation%20therapy%5C%22%20center%20for%20treatment%20of%20claudication.%20Previous%20testing%20%28one%20day%20before%29%20showed%20the%20serum%20creatinine%20level%20to%20be%205.0%20mg%5C%2FdL.%20An%20estimated%20creatinine%20clearance%20was%2019%20mL%5C%2Fmin.%20The%20serum%20hematocrit%20value%20was%2029.4%25.%20To%20be%20prepared%20for%20chelation%5Cu2014the%20intravenous%20%28IV%29%20administration%20of%20edetic%20acid%5Cu2014the%20patient%20was%20given%202.5%20g%20of%20vitamin%20C%20in%20500%20mL%20of%20solution%20of%205%25%20dextrose%20in%20water%20for%20five%20hours.%20The%20patient%20tolerated%20the%20infusion%20well%3B%20however%2C%2012%20hours%20later%20he%20experienced%20severe%20lancinating%20bilateral%20flank%20pain%2C%20passed%203%20mL%20of%20hematuria%2C%20and%20became%20anuric.The%20patient%20was%20transferred%20to%22%2C%22date%22%3A%221984-10-05%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1001%5C%2Fjama.1984.03350130016019%22%2C%22ISSN%22%3A%220098-7484%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1984.03350130016019%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T20%3A50%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22MCMPZANG%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Williams%20et%20al.%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EAcute%20Kidney%20Injury%20From%20Biopsy-Proven%20Renal%20Oxalosis%20From%20Excessive%20Intake%20of%20Vitamin%20C%20Leading%20to%20End-Stage%20Kidney%20Disease%3C%5C%2Fb%3E%23%23%21Williams%20R%2C%20Dauleh%20M%2C%20et%20al.%20%7C%20%3Ci%3ECureus%3C%5C%2Fi%3E.%2014%2812%29%3Ae33061.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7759%5C%2Fcureus.33061%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7759%5C%2Fcureus.33061%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Kidney%20Injury%20From%20Biopsy-Proven%20Renal%20Oxalosis%20From%20Excessive%20Intake%20of%20Vitamin%20C%20Leading%20to%20End-Stage%20Kidney%20Disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mujahed%22%2C%22lastName%22%3A%22Dauleh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Abendroth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gurwant%22%2C%22lastName%22%3A%22Kaur%22%7D%5D%2C%22abstractNote%22%3A%22We%20are%20presenting%20a%20case%20of%20a%2055-year-old%20Caucasian%20female%20who%20presented%20with%20acute%20kidney%20injury%20requiring%20hemodialysis.%20Her%20native%20kidney%20biopsy%20showed%20extensive%20crystals%20in%20both%20the%20cortex%20and%20medulla%2C%20morphologically%20consistent%20with%20calcium%20oxalate%20crystals.%20The%20etiology%20was%20attributed%20to%20vitamin%20C-induced%20kidney%20hyperoxaluria.%20She%20has%20remained%20hemodialysis%20dependent%20for%20more%20than%20three%20months%20since%20the%20initial%20presentation%2C%20establishing%20a%20diagnosis%20of%20end-stage%20kidney%20disease.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.7759%5C%2Fcureus.33061%22%2C%22ISSN%22%3A%222168-8184%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC9883020%5C%2F%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-02-04T18%3A03%3A00Z%22%7D%7D%5D%7D
Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report##!2007 | Rathi S, Kern W, et al. | Journal of Medical Case Reports. 2007;1(1):155. ##!http://doi.org/10.1186/1752-1947-1-155
Ascorbate Increases Human Oxaluria and Kidney Stone Risk##!2005 | Massey LK, Liebman M, et al. | The Journal of Nutrition. 2005;135(7):1673-1677. ##!http://doi.org/10.1093/jn/135.7.1673
Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration##!1985 | Lawton JM, Conway LT, et al. | Archives of Internal Medicine. 1985;145(5):950-951. ##!http://doi.org/10.1001/archinte.1985.00360050220044
Renal Failure Secondary to Massive Infusion of Vitamin C##!1984 | McAllister CJ, Scowden EB, et al. | JAMA. 1984;252(13):1684. ##!http://doi.org/10.1001/jama.1984.03350130016019
Acute Kidney Injury From Biopsy-Proven Renal Oxalosis From Excessive Intake of Vitamin C Leading to End-Stage Kidney Disease##!Williams R, Dauleh M, et al. | Cureus. 14(12):e33061. ##!http://doi.org/10.7759/cureus.33061